Avidity
Garineh M. has a diverse work experience spanning different companies and roles. Garineh started their career as a Staff Accountant at KPMG Peat Marwick in 2008, where they worked until 2009. In 2018, they joined Phanes Therapeutics Inc. as an Assistant Scientist I and remained there until 2019. Following that, they interned at Sanford Burnham Prebys Medical Discovery Institute from 2019 to 2020. In 2020, they worked as a Contractor (Cell Biology) at Thermo Fisher Scientific for a brief period from June to August. Currently, Garineh is employed at Avidity Biosciences, Inc. where they began as a Research Associate in September 2020. Garineh was recently promoted to the position of Senior Research Associate in January 2022.
Garineh M. completed their undergraduate education at California State University, Fresno from 2005 to 2008, where they earned a Bachelor of Science degree in Accounting. In 2016 to 2017, they attended San Diego State University and obtained a Teaching Credential in Single-Subject Science Credential in Biology. Later in 2019, Garineh pursued Post-Baccalaureate Training in Biotechnology at California State University San Marcos, which they completed in 2020.
This person is not in the org chart
Avidity
2 followers
Avidity Biosciences is pioneering a new class of precision medicines – antibody-siRNA conjugates (ASC™) – to deliver nucleic acid therapeutics against genetic drivers of disease. Our ASCs have drug-like properties similar to antibodies and antibody-drug conjugates. Importantly, their unique siRNA-based “payloads” permit selective targeting of disease-associated mRNAs against virtually any target of interest.